Tal Brosh-Nissimov
Head of Infectious Diseases Unit
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (14)
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Resistance of SARS-CoV-2 to antivirals was shown to develop in immunocompromised individuals receiving remdesivir. We describe an immunocompromised patient who was treated with repeated and prolonged courses of nirmatrelvir and developed de-novo E166V/L50F mutations in the Mpro region. These mutations were associated with clinical and virological treatment failure.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (2)
Sharon Ovnat Tamir
Head of Otology/Neurotology Unit
-
ISRAEL
Amos Cahan
-
ISRAEL
Make your next move.
Prepare your application
Review drafts before you send them.